News about

Solara Active Pharma Sciences' Cuddalore facility completes WHO PQ inspection

The Cuddalore API site is a multi-product facility
<br />

| 27/01/2023 | By |  1643

ENTOD Pharma's state-of-the-art R&D facility opens in Navi Mumbai

The brand new additional R&D facility in Navi Mumbai has been designed with state-of-the-art equipment and the latest analytical & formulation research tools

| 27/01/2023 | By |  917

Torrent Pharma gets US FDA warning letter for Gujarat facility

The company said that this inspection classification will not have an impact on existing supplies or revenues from this facility

| 25/01/2023 | By |  1856

Eli Lilly plans $450 M expansion plans

The company will increase the headcount by 100 more employees.

| 25/01/2023 | By |  648

US FDA inspects Indoco Remedies' solid oral formulation facility in Goa

The inspection was conducted from January 16 to 20, 2023

| 24/01/2023 | By |  629

Marksans Pharma announces UK MHRA approval for Fluoxetine 20mg/5ml oral solution

The product will be manufactured at the plant of Bell, Sons & Co, UK

| 24/01/2023 | By |  609

Lupin recalls 16,056 bottles of Rifampin capsules to treat TB

Manufacturing issues were cited

| 23/01/2023 | By |  1339

Upperton Pharma Solutions begins construction work at Nottingham facility

Work has now started in earnest to deliver the new, 50,000-square-foot facility, which is expected to be fully operational by the end of 2023

| 23/01/2023 | By |  403

Strides Pharma completes WHO PQ inspection at Puducherry facility

The inspection was carried out between January 16-20, 2023

| 23/01/2023 | By |  1183

Stelis Biopharma's facility receives EIR from US FDA

The company received the EIR from USFDA for the drug-device combination to be commercialised from the company's flagship facility in Bengaluru<br />

| 20/01/2023 | By |  1110